Author

Cristina R. Ferrone

Observed names: C. Ferrone, Cristina Ferrone, Cristina R Ferrone

Institutions: Cedars-Sinai Medical Center, Harvard University, Massachusetts General Hospital

Observed institutions: Cedars-Sinai Medical Center, Harvard University, Massachusetts General Hospital

OpenAlex ID: A5111040636

B7-H3: An Attractive Target for Antibody-based Immunotherapy

2020 · Filippos Kontos, Theodoros Michelakos, et al. · Clinical Cancer Research · 392

PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma

2015 · Francesco Sabbatino, Vincenzo Villani, et al. · Clinical Cancer Research · 217

The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

2024 · Arsen Osipov, Ognjen Nikolic, et al. · Nature Cancer · 99

PDF

Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs)

2019 · Lei Cai, Theodoros Michelakos, et al. · Clinical Cancer Research · 76

212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models

2017 · Benjamin B. Kasten, Abhishek Gangrade, et al. · Nuclear Medicine and Biology · 62

Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy

2023 · Marco Ventin, Giulia Cattaneo, et al. · JAMA Oncology · 52

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

2023 · Yufeng Wang, David L. Drum, et al. · Nature Communications · 45

PDF

Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

2024 · Jordan M. Cloyd, Angela Sarna, et al. · JAMA Surgery · 17

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants

2025 · Or-Yam Revach, Angelina M. Cicerchia, et al. · Cell Reports Medicine · 12

HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactions

2024 · Chenyue Lu, Amaya Pankaj, et al. · Hepatology Communications · 11

Novel Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy to Eradicate Both Differentiated Cancer Cells and Cancer-Initiating Cells in Solid Tumors

2014 · Francesco Sabbatino, Yangyang Wang, et al. · Seminars in Oncology · 10

Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy

2022 · Ahmed O. Elzoghby, Cristina R. Ferrone, et al. · Drug Discovery Today · 9

Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma

2024 · Giulia Cattaneo, Marco Ventin, et al. · Cancer Letters · 7

Single-cell transcriptomics reveals the impact of sex and age in the healthy human liver

2026 · Raza Ur Rahman, Eliana T. Epstein, et al. · JHEP Reports · 6

PDF

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer

2025 · Giulia Cattaneo, Marco Ventin, et al. · Journal of Experimental & Clinical Cancer Research · 6

PDF

Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence

2013 · Yangyang Wang, Francesco Sabbatino, et al. · Resistance to targeted anti-cancer therapeutics · 4

Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation

2014 · Francesco Sabbatino, Yangyang Wang, et al. · Cancer Research · 2

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

2024 · Murtaza Ahmed, Marco Ventin, et al. · Journal of Clinical Oncology · 1

PDF

Single Cell Spatial Transcriptomic Profiling Identifies a LINE1 Associated Disarrayed Immune Microenvironment in Hepatocellular Carcinoma

2023 · Avril K. Coley, Cole Nawrocki, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

PDF

Pathological complete response in a POLE-mutated non-small cell lung cancer patient treated with perioperative chemoimmunotherapy: a case report and review of the literature

2026 · Luigi Liguori, Rosario De Feo, et al. · MedScience

Abstract 4286: B7-H3 hypoimmune chimeric antigen receptor T cells overcome immune rejection and retain antitumor activity against cholangiocarcinoma

2026 · Chiara Camillo, Xiaomeng Hu, et al. · Cancer Research

Abstract 7459: Localized co-delivery of hyaluronidase enhances CSPG4 CAR-T cells cytotoxicity against chordoma

2026 · Maoyang Qi, Giulia Cattaneo, et al. · Cancer Research

Abstract 6446: Molecular profiling to predict the first site of recurrence in pancreatic cancer patients receiving neoadjuvant therapy followed by surgery

2026 · Luigi Liguori, Marco Ventin, et al. · Cancer Research

Abstract 6535: Enhancing NSCLC susceptibility to anti-PD-1 - PD-L1 therapy trough PD-L1 ligand-Ir(III) complex conjugates

2026 · Valentina Pagliara, Giulia Assoni, et al. · Cancer Research

BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target